CORZ pulls back as sellers dominate the short-term trend
Core Scientific (CORZ) stock is trading at $17.57 after falling 3.33% on the day. The price sits below its short- and medium-term moving averages, as well as below the long-term average, indicating persistent pressure after a volatile session.
Highlights
- Core Scientific posted year-on-year gains in both revenue and net income, showing operational expansion and stronger profitability.
- Recent results indicate tangible demand or cost improvements, but shares remain under selling pressure.
- Shares of Core Scientific closed at $17.57 after a 3.33% drop, with technical signals mostly bearish and a predicted trading range of $16.97 to $18.34 in the next two to three days.
Earnings momentum offset by broad selling in post-report trading
Core Scientific reported year-on-year revenue and net income growth, indicating the company achieved operational expansion and improved profitability, as noted by Simplywall. This growth demonstrates execution on business fundamentals and signals that recent results reflected concrete demand or cost improvements. Nevertheless, price action has remained under broader selling pressure.
Technical signals diverge as volatility and bearish momentum dominate
On the daily chart, CORZ sits below its MA-20, MA-50, and MA-200, with immediate resistance at the Ichimoku Kijun level of $18.43. RSI reads 46.92 and, alongside CCI, signals Sell; meanwhile, Stoch RSI is Oversold, which could mark exhaustion in selling. MACD remains Neutral and ADX signals Buy, yet momentum overall tilts bearish as both Bull/Bear Power and the Awesome Oscillator confirm a selling bias. Elevated volatility and a close near session lows underline prevailing downside momentum, but divergences in ADX and Stoch RSI hint at conflicting short-term signals.
Consolidation risk rises with downside more likely barring resistance break
In the upcoming 2–3 trading days, CORZ is expected to consolidate within the $16.97 to $18.34 range. The probability of a downward move is estimated at 62%, with a 38% likelihood of a rebound. A move above $18.43 would be needed to shift momentum to the upside, while a drop through $16.97 support could prompt further selling in the short term.
Earlier, analysts noted that digital asset treasury companies have largely lost their valuation premium, reflecting diminished investor willingness to pay extra for crypto-related public equities. Against this broader backdrop, Core Scientific’s persistent trading below key moving averages and consolidating near support levels highlights the importance of monitoring $16.97 as a critical downside risk in the coming sessions.